Tyra Biosciences, Inc. (TYRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.57B |
| Enterprise Value | 1.5B |
| P/E Ratio | -12.99 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.51 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -12.29 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.32 |
| Return On Equity | -0.43 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -119.4M |
| Net Income | -119.95M |
| Diluted EPS | -2.01 |
| Total Cash | 383.47M |
| Total Cash/Share | 6.21 |
| Total Debt | 5.7M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 20.49 |
| Book Value Per Share | 6.28 |
| 52-Week Change | 191.66 |
| 52-Week High | 40.65 |
| 52-Week Low | 8.98 |
| Moving Average 50 Days | 32.84 |
| Moving Average 200 Days | 26.18 |
| Average Volume | 955,059 |
| Shares Outstanding | 59.47M |
| % Held by Institutions | 110.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |